- Home
- » Tags
- » Vaccine trial
Top View
- Vaccine Clinical Trials and Data Infrastructure
- Current State of the First COVID-19 Vaccines
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices
- VAERS) Standard Operating Procedures for COVID-19 (As of 29 January 2021)
- Effectiveness of the Pfizer-Biontech and Oxford-Astrazeneca Vaccines
- COVID-19 Vaccine Frequently Asked Questions
- COVID-19 Mrna Vaccine FAQ
- Ethical Considerations for Current and Future COVID-19 Placebo-Controlled Vaccine Trials and Trial Unblinding Policy Brief 18 December 2020
- Reviewing Clinical Trials: a Guide for the Ethics Committee
- 2023 Before We Have Enough Doses for the Whole World
- CLINICAL CONSIDERATIONS for COVID-19 VACCINATION February 26, 2021 CONTINUING EDUCATION
- Thimerosal Timeline
- Clinical Study First Sub-Protocol
- WHAT HAPPENS AFTER a COVID-19 VACCINE TRIAL SUCCEEDS? Four Pharmacovigilance Challenges to Address During Commercialization
- Endpoints in Vaccine Trials
- FDA Briefing Document: Moderna COVID-19 Vaccine
- CDC Global Immunization Strategic Framework 2021-2030 with Immunization Agenda 2030 and Gavi 5.0
- Covid-19 Vaccine Trial Protocols Released
- COVID-19 Vaccine Candidates Information Updated: 05/11/2021
- Design of Vaccine Efficacy Trials to Be Used During Public Health Emergencies – Points of Considerations and Key Principles
- Current Clinical Trials Protocols and the Global Effort for Immunization
- Vaccine Research and Development November 2009
- Johns Hopkins Vaccine Initiative
- Algorithm for the Support of Non-Related (Serious) Adverse Events in an Ebola Vaccine Trial in the Democratic Republic of the Co
- Overview of Planned and Ongoing Clinical Studies of Vaccines for COVID-19
- Transparency of COVID-19 Vaccine Trials: Decisions Without Data
- For Whose Benefit? Transparency in the Development and Procurement of COVID-19 Vaccines
- Immunological Mechanisms of Vaccine-Induced Protection Against COVID-19 in Humans
- Accountability of International Ngos: Human Rights Violations In
- Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
- Overview and Considerations for COVID-19 Vaccines
- NBER WORKING PAPER SERIES a COST/BENEFIT ANALYSIS of CLINICAL TRIAL DESIGNS for COVID-19 VACCINE CANDIDATES Donald A. Berry Scot
- Study of Awareness Regarding Covid-19 Vaccines Among General Population
- WHAT HAPPENS AFTER a COVID-19 VACCINE TRIAL SUCCEEDS? Four Pharmacovigilance Challenges to Address During Commercialization
- Outrage Over Vaccine- Trial Scandal at Peruvian
- COVID-19 Vaccine Update August 24, 2021
- ACIP Meeting Minutes October 24-25, 2007
- No Let-Up in Covid-19 Vaccine Trials
- COVID-19 Vaccine Development and Delivery: the Nemesis, the Hubris, and the Elpis
- How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID‑19 Vaccine
- Reporting and Interpreting the Numerical Results of a Vaccine Trial: a Practical Guide for Students and Health Care Professionals
- SARS-Cov-2 Vaccine Testing and Trials in the Pediatric Population: Biologic, Ethical, Research, and Implementation Challenges
- WHO Prioritisation of COVID-19 Vaccine Allocation
- Vaccine Update September 24, 2021
- COVID-19 VACCINES Based on Available Evidence up to 16 November 2020
- Antibody Response to Inactivated COVID-19 Vaccine (Coronavac)
- Types of Epidemiologic Studies
- The Effect of Pandemic Prevalence on the Reported Efficacy of SARS
- A Summary of the SARS-Cov-2 Vaccines and Technologies Available Or Under Development
- COVID-19 Vaccine Candidates Information Updated: 02/12/2021
- Guidelines on Clinical Evaluation of Vaccines: Regulatory Expectations